Skip to main navigation Skip to search Skip to main content

Ganoderma lucidum combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib synergize to reduce inflammatory breast cancer progression

  • Ivette J. Suárez-Arroyo
  • , Tiffany J. Rios-Fuller
  • , Yismeilin R. Feliz-Mosquea
  • , Mercedes Lacourt-Ventura
  • , Daniel J. Leal-Alviarez
  • , Gerónimo Maldonado-Martinez
  • , Luis A. Cubano
  • , Michelle M. Martínez-Montemayor

Research output: Contribution to journal › Article › peer-review

32   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Ganoderma lucidum combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib synergize to reduce inflammatory breast cancer progression'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology